Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Margaret Knowles

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|February 21, 2006
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancerRosamonde E Banks, Prasanna Tirukonda, Claire Taylor, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 VirusNicola E Annels, Mehreen Arif, Guy R Simpson, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 9, 2020
Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective studyLeonardo Calo, Marco Rebecchi, Antonella Sette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
British Journal of Cancer|May 12, 2020
Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasionNick Hornigold, Karen R Dunn, Rachel A Craven, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Elife|June 28, 2017
Affimer proteins are versatile and renewable affinity reagentsChristian Tiede, Robert Bedford, Sophie J Heseltine, et al.
Nature|October 1, 2004
Lung cancer: intragenic ERBB2 kinase mutations in tumoursPhilip Stephens, Chris Hunter, Graham Bignell, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Research|February 21, 2006
Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancerRosamonde E Banks, Prasanna Tirukonda, Claire Taylor, et al.
Molecular Therapy Oncolytics|July 11, 2018
Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 VirusNicola E Annels, Mehreen Arif, Guy R Simpson, et al.
Human Mutation|January 2, 2009
IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumorsFonnet E Bleeker, Simona Lamba, Sieger Leenstra, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 9, 2020
Catheter ablation of right atrial ganglionated plexi to treat cardioinhibitory neurocardiogenic syncope: a long-term follow-up prospective studyLeonardo Calo, Marco Rebecchi, Antonella Sette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation studyLars Dyrskjøt, Karsten Zieger, Francisco X Real, et al.
British Journal of Cancer|May 12, 2020
Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasionNick Hornigold, Karen R Dunn, Rachel A Craven, et al.
Urologic Oncology|July 29, 2014
Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forwardAndrea B Apolo, Vanessa Hoffman, Matthew G Kaag, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 5, 2016
Summary and Recommendations from the National Cancer Institute's Clinical Trials Planning Meeting on Novel Therapeutics for Non-Muscle Invasive Bladder CancerSeth P Lerner, Dean F Bajorin, Colin P Dinney, et al.
Elife|June 28, 2017
Affimer proteins are versatile and renewable affinity reagentsChristian Tiede, Robert Bedford, Sophie J Heseltine, et al.
Nature|October 1, 2004
Lung cancer: intragenic ERBB2 kinase mutations in tumoursPhilip Stephens, Chris Hunter, Graham Bignell, et al.
Pageof 2